$CRD-A

CRAWFORD JESSE C sold (to issuer) 11,111 shares of CRD-A

CRAWFORD JESSE C sold (to issuer) 11,111 shares of CRAWFORD & CO (CRD-A) on 2026-06-01.

Original reporting
SEC EDGAR · CRAWFORD JESSE C
Published Jun 2, 2026, 7:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 7:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CRD-A
Neutral
medium confidence
Mentioned
$CRD-A
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CRD-ANeutralLow
01

Why it matters

The disclosure updates insider holdings but provides no new operational or financial information; the lack of disclosed price/value limits inference.

02

Market read

Primarily a compliance/ownership update; likely low trading impact absent additional corroborating news.

03

What to watch

Code 'D' (sale to issuer) can be routine (e.g., buyback participation) and may not reflect market expectations; absence of price/value reduces interpretability.

Relevance 4/10Novelty 3/10Timing: Filed 2026-06-02; transaction dated 2026-06-01.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Crawford & Co (CRD-A).

Company-level read

Ticker impact

$CRD-ANeutralMedium confidence
Context

SEC Form 4 shows 10% owner Jesse C Crawford sold 11,111 shares of CRD-A to the issuer on 2026-06-01.

Expected impact

Minimal near-term impact; treat as routine insider activity unless repeated or paired with other disclosures.

Evidence & confidence

The filing is an ownership-change disclosure without disclosed transaction value, and it does not indicate new company fundamentals or guidance.

Market effects

None—single-company insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

If the sale is part of a larger pattern (multiple Form 4s) it could reflect liquidity needs rather than bearish views; monitor for clustering.

Key entities

  • CRAWFORD & CO

    Subject of the SEC Form 4 insider transaction (CRD-A).

  • CRAWFORD JESSE C

    10% owner who sold 11,111 shares to the issuer on 2026-06-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRD-AMedAI 8/10

Crawford & Company Reports 2026 Third Quarter Results

Crawford & Company (CRD-A, CRD-B) reported Q3 2026 revenues of $321.6M, down slightly from $322.2M in Q3 2025. Net income rose to $15.0M ($0.31 per share) from $12.4M ($0.25 per share). International operations drove improved performance, while U.S. segments saw declines. The CEO highlighted progress in cost management and client relationships, but expects fourth-quarter pressure from lower claims frequency.

$CRD-AMed

CRAWFORD & COMPANY REPORTS 2026 SECOND QUARTER RESULTS

CRAWFORD & CO (CRD-A) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Crawford & Company® 5335 Triangle Parkway Peachtree Corners, GA 30092 FOR IMMEDIATE RELEASE CRAWFORD & COMPANY REPORTS 2026 SECOND QUARTER RESULTS Strong Earnings Growth Driven by International Operations and Broadspire Quarterly Dividend Increases to $0.08 per Share

$ASPEMedAI 8/10

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $18.0M of ASPE (indirect holdings)

ARCH Venture Fund X, L.P. purchased 1,200,000 indirectly-held shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($18.00M total) on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

$ASPELow

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $2.0M of ASPE

ARCH Venture Fund X, L.P. purchased 133,333 shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($2.00M total) across 2 trades on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).